Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistence Of Major Molecular Remission In Chronic Myeloid Leukemia After A Second Stop Of Tki Treatment In Patients Who Failed An Initial Stop Attempt: A Multicenter Prospective Trial

NCT03573596 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT03573596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03573596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistence Of Major Molecular Remission In Chronic Myeloid Leukemia After A Second Stop Of Tki Treatment In Patients Who Failed An Initial Stop Attempt: A Multicenter Prospective Trial
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Phase 2
Overall status
Unknown status
Start date
February 1, 2018
Completion date
February 1, 2024
Enrollment
134 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

cml, relapsed